Seres TherapeuticsCambridge, Massachusetts, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
2067 - Preclinical Characterization of Rationally Designed Microbial Consortia to Prevent Bacterial Infections in Patients with Chronic Liver Disease
Saturday, October 14, 202311:30 AM – 11:43 AM US ET